Phase IIB, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19
Jara Rubio$n$ et al., European Journal of Haematology, doi:10.1111/ejh.70214
https://c19early.org/jararubio.html